BenzingaOctober 14, 2026 at 9:19 AM NY13 Days Ago
Oppenheimer Reiterates Outperform on Xylem, Lowers Price Target to $150
Oppenheimer analyst Bryan Blair reiterates Xylem (NYSE:XYL) with a Outperform and lowers the price target from $158 to $150.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
